Skip to main content
SpringerLink
Log in

Inhibitors of the Plasmodium Mitochondrial Respiratory Chain

  • Living reference work entry
  • First Online:
Book cover Encyclopedia of Malaria

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Baldwin J, Farajallah AM, Malmquist NA, Rathod PK, Phillips MA. Malarial dihydroorotate dehydrogenase. J Biol Chem. 2002;277(44):41827–34.

    Article  CAS  PubMed  Google Scholar 

  • Baldwin J, Michnoff CH, Malmquist NA, White J, Roth MG, Rathod PK, Phillips MA. High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. J Biol Chem. 2005;280(23):21847–53.

    Article  CAS  PubMed  Google Scholar 

  • Barton V, Fisher N, Biagini GA, Ward SA, O'Neill PM. Inhibiting Plasmodium cytochrome bc1: a complex issue. Curr Opin Chem Biol. 2010;14(4):440–6.

    Article  CAS  PubMed  Google Scholar 

  • Biagini GA, Fisher N, Berry N, Stocks PA, Meunier B, Williams DP, Bonar-Law R, Bray PG, Owen A, O'Neill PM, Ward SA. Acridinediones: selective and potent inhibitors of the Malaria parasite mitochondrial bc1 complex. Mol Pharmacol. 2008;73(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):1347–55.

    Article  CAS  PubMed  Google Scholar 

  • Biagini GA, Fisher N, Shone AE, Mubaraki MA, Srivastava A, Hill A, Antoine T, Warman AJ, Davies J, Pidathala C, Amewu RK, Leung SC, Sharma R, Gibbons P, Hong DW, Pacorel B, Lawrenson AS, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Stocks PA, Nixon GL, Chadwick J, Hemingway J, Delves MJ, Sinden RE, Zeeman AM, Kocken CHM, Berry NG, O’Neill PM, Ward SA. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. Proc Natl Acad Sci U S A. 2012;109(21):8298–303.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Boa AN, Canavan SP, Hirst PR, Ramsey C, Stead AMW, McConkey GA. Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase. Bioorg Med Chem. 2005;13(6):1945–67.

    Article  CAS  PubMed  Google Scholar 

  • Booker ML, Bastos CM, Kramer ML, Barker Jr RH, Skerlj R, Sidhu AB, Deng X, Celatka C, Cortese JF, Bravo JEG, Llado KNC, Serrano AE, Angulo-Barturen I, Belen Jimenez-Diaz M, Viera S, Garuti H, Wittlin S, Papastogiannidis P, Lin JW, Janse CJ, Khan SM, Duraisingh M, Coleman B, Goldsmith EJ, Phillips MA, Munoz B, Wirth DF, Klinger JD, Wiegand R, Sybertz E. Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model. J Biol Chem. 2010;285(43):33054–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bueno JM, Manzano P, Garcia MC, Chicharro J, Puente M, Lorenzo M, Garcia A, Ferrer S, Gomez RM, Fraile MT, Lavandera JL, Fiandor JM, Vidal J, Herreros E, Gargallo-Viola D. Potent antimalarial 4-pyridones with improved physico-chemical properties. Bioorg Med Chem Lett. 2011;21(18):5214–8 (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved.).

    Article  CAS  PubMed  Google Scholar 

  • Bulusu V, Jayaraman V, Balaram H. Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum. J Biol Chem. 2011;286(11):9236–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cheung TW. Overdose of atovaquone in a patient with AIDS. AIDS. 1999;13(14):1984–5.

    Article  CAS  PubMed  Google Scholar 

  • Coteron JM, Marco M, Esquivias J, Deng X, White KL, White J, Koltun M, El Mazouni F, Kokkonda S, Katneni K, Bhamidipati R, Shackleford DM, Angulo-Barturen I, Ferrer SB, Belen Jimenez-Diaz M, Gamo F-J, Goldsmith EJ, Charman WN, Bathurst I, Floyd D, Matthews D, Burrows JN, Rathod PK, Charman SA, Phillips MA. Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. J Med Chem. 2011;54(15):5540–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cowley R, Leung S, Fisher N, Al-Helal M, Berry NG, Lawrenson AS, Sharma R, Shone AE, Ward SA, Biagini GA, O'Neill PM. The development of quinolone esters as novel antimalarial agents targeting the Plasmodium falciparum bc1 protein complex. MedChemComm. 2012;3:39–44 (Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved.).

    Article  CAS  Google Scholar 

  • da Cruz FP, Martin C, Buchholz K, Lafuente-Monasterio MJ, Rodrigues T, Sonnichsen B, Moreira R, Gamo FJ, Marti M, Mota MM, Hannus M, Prudencio M. Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug. J Infect Dis. 2012;205(8):1278–86.

    Article  PubMed Central  PubMed  Google Scholar 

  • Dembele L, Gego A, Zeeman AM, Franetich JF, Silvie O, Rametti A, Le Grand R, Dereuddre-Bosquet N, Sauerwein R, van Gemert GJ, Vaillant JC, Thomas AW, Snounou G, Kocken CH, Mazier D. Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One. 2011;6(3):e18162.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Deng X, Gujjar R, El Mazouni F, Kaminsky W, Malmquist NA, Goldsmith EJ, Rathod PK, Phillips MA. Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds. J Biol Chem. 2009;284(39):26999–7009.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fisher N, Majid RA, Antoine T, Al-Helal M, Warman AJ, Johnson DJ, Lawrenson AS, Ranson H, O'Neill PM, Ward SA, Biagini GA. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite Results in reduced parasite bc(1) catalytic turnover and protein expression. J Biol Chem. 2012;287(13):9731–41.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fry M, Pudney M. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566c80). Biochem Pharmacol. 1992;43(7):1545–53.

    Article  CAS  PubMed  Google Scholar 

  • Gujjar R, El Mazouni F, White KL, White J, Creason S, Shackleford DM, Deng X, Charman WN, Bathurst I, Burrows J, Floyd DM, Matthews D, Buckner FS, Charman SA, Phillips MA, Rathod PK. Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. J Med Chem. 2011;54(11):3935–49.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gujjar R, Marwaha A, El Mazouni F, White J, White KL, Creason S, Shackleford DM, Baldwin J, Charman WN, Buckner FS, Charman S, Rathod PK, Phillips MA. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. J Med Chem. 2009;52(7):1864–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Haile LG, Flaherty JF. Atovaquone – a review. Ann Pharmacother. 1993;27(12):1488–94.

    CAS  PubMed  Google Scholar 

  • Hammond DJ, Burchell JR, Pudney M. Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro. Mol Biochem Parasitol. 1985;14(1):97–109.

    Article  CAS  PubMed  Google Scholar 

  • Heikkila T, Thirumalairajan S, Davies M, Parsons MR, McConkey AG, Fishwick CWG, Johnson AP. The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Bioorg Med Chem Lett. 2006;16(1):88–92.

    Article  PubMed  Google Scholar 

  • Hudson AT. Atovaquone – a novel broad-spectrum antiinfective drug. Parasitol Today. 1993;9(2):66–8.

    Article  CAS  PubMed  Google Scholar 

  • Hudson AT, Randall AW, Fry M, Ginger CD, Hill B, Latter VS, Mchardy N, Williams RB. Novel anti-malarial hydroxynaphthoquinones with potent broad-spectrum anti-protozoal activity. Parasitology. 1985;90(Feb):45–55.

    Article  CAS  PubMed  Google Scholar 

  • Hughes WT, Kennedy W, Shenep JL, Flynn PM, Hetherington SV, Fullen G, Lancaster DJ, Stein DS, Palte S, Rosenbaum D, et al. Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. J Infect Dis. 1991;163(4):843–8.

    Article  CAS  PubMed  Google Scholar 

  • Hurt DE, Widom J, Clardy J. Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor. Acta Crystallogr D Biol Crystallogr. 2006;62:312–23.

    Article  PubMed  Google Scholar 

  • Hussein Z, Eaves J, Hutchinson DB, Canfield CJ. Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin Pharmacol Ther. 1997;61(5):518–30.

    Article  CAS  PubMed  Google Scholar 

  • Jimenez-Diaz MB, Mulet T, Viera S, Gomez V, Garuti H, Ibanez J, Alvarez-Doval A, Shultz LD, Martinez A, Gargallo-Viola D, Angulo-Barturen I. Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rγnull mice engrafted with human erythrocytes. Antimicrob Agents Chemother. 2009;53(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):4533–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kelly JX, Smilkstein MJ, Brun R, Wittlin S, Cooper RA, Lane KD, Janowsky A, Johnson RA, Dodean RA, Winter R, Hinrichs DJ, Riscoe MK. Discovery of dual function acridones as a new antimalarial chemotype. Nature (London, UK). 2009;459(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):270–3.

    Article  CAS  Google Scholar 

  • Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother. 2000;44(8):2100–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • LaRocque RC, Rao SR, Lee J, Ansdell V, Yates JA, Schwartz BS, Knouse M, Cahill J, Hagmann S, Vinetz J, Connor BA, Goad JA, Oladele A, Alvarez S, Stauffer W, Walker P, Kozarsky P, Franco-Paredes C, Dismukes R, Rosen J, Hynes NA, Jacquerioz F, McLellan S, Hale D, Sofarelli T, Schoenfeld D, Marano N, Brunette G, Jentes ES, Yanni E, Sotir MJ, Ryan ET. Global TravEpiNet: a national consortium of clinics providing care to international travelers–analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009–2011. Clin Infect Dis. 2012;54(4):455–62.

    Article  PubMed  Google Scholar 

  • Leung SC, Gibbons P, Amewu R, Nixon GL, Pidathala C, Hong WD, Pacorel B, Berry NG, Sharma R, Stocks PA, Srivastava A, Shone AE, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Hill A, Fisher NE, Warman AJ, Biagini GA, Ward SA, O'Neill PM. Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2). J Med Chem. 2012;55(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):1844–57.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DBA, Grp MCTS. Malarone (R) (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Am J Trop Med Hyg. 1999;60(4):533–41.

    CAS  PubMed  Google Scholar 

  • Marwaha A, White J, El Mazouni F, Creason SA, Kokkonda S, Buckner FS, Charman SA, Phillips MA, Rathod PK. Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase. J Med Chem. 2012;55(17):7425–36.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • McKeage K, Scott LJ. Atovaquone/proguanil – a review of its use for the prophylaxis of Plasmodium falciparum malaria. Drugs. 2003;63(6):597–623.

    Article  CAS  PubMed  Google Scholar 

  • Nakato H, Vivancos R, Hunter PR. A systematic review and meta-analysis of the effectiveness and safety of atovaquone-proguanil (Malarone) for chemoprophylaxis against malaria. J Antimicrob Chemother. 2007;60(5):929–36.

    Article  CAS  PubMed  Google Scholar 

  • Nilsen A, Lacrue AN, White KL, Forquer IP, Cross RM, Marfurt J, Mather MW, Delves MJ, Shackleford DM, Saenz FE, Morrisey JM, Steuten J, Mutka T, Li Y, Wirjanata G, Ryan E, Duffy S, Kelly JX, Sebayang BF, Zeeman A-M, Noviyanti R, Sinden RE, Kocken CHM, Price RN, Avery VM, Angulo-Barturen I, Jimenez-Diaz MB, Ferrer S, Herreros E, Sanz LM, Gamo F-J, Bathurst I, Burrows JN, Siegl P, Guy RK, Winter RW, Vaidya AB, Charman SA, Kyle DE, Manetsch R, Riscoe MK. Quinolone-3-diarylethers: a new class of antimalarial drug. Sci Transl Med. 2013;5(Copyright (C) 2013 U.S. National Library of Medicine):177ra137.

    Google Scholar 

  • Nixon GL, Moss DM, Shone AE, Lalloo DG, Fisher N, O'Neill PM, Ward SA, Biagini GA. Antimalarial pharmacology and therapeutics of atovaquone. J Antimicrob Chemother. 2013a;68(5):977–85.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nixon GL, Pidathala C, Shone AE, Antoine T, Fisher N, O’Neill PM, Ward SA, Biagini GA. Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era. Future Med Chem. 2013b;5(13):1573–91.

    Article  CAS  PubMed  Google Scholar 

  • Osei-Akoto A, Orton LC, Owusu-Ofori S. Atovaquone-proguanil for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009;2005CD004529(4):1–53.

    Google Scholar 

  • Patel V, Booker M, Kramer M, Ross L, Celatka CA, Kennedy LM, Dvorin JD, Duraisingh MT, Sliz P, Wirth DF, Clardy J. Identification and characterization of small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. J Biol Chem. 2008;283(50):35078–85.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Phillips MA, Gujjar R, Malmquist NA, White J, El Mazouni F, Baldwin J, Rathod PK. Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum. J Med Chem. 2008;51(12):3649–53.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Pidathala C, Amewu R, Pacorel B, Nixon GL, Gibbons P, Hong WD, Leung SC, Berry NG, Sharma R, Stocks PA, Srivastava A, Shone AE, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Hill A, Fisher NE, Warman AJ, Biagini GA, Ward SA, O'Neill PM. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2). J Med Chem. 2012;55(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):1831–43.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Riscoe M, Winter R, Kelly J, Smilkstein M, Dodean R, Hinrichs D. Evaluation and lead optimization of antimalarial aromatic ketones. Am J Trop Med Hyg. 2006;75(5):97–8.

    Google Scholar 

  • Rolan PE, Mercer AJ, Tate E, Benjamin I, Posner J. Disposition of atovaquone in humans. Antimicrob Agents Chemother. 1997;41(6):1319–21.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Rolan PE, Mercer AJ, Weatherley BC, Holdich T, Meire H, Peck RW, Ridout G, Posner J. Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol. 1994;37(1):13–20.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Salzer W, Timmler H, Andersag H. A new type of compounds active against avian malaria. Chem Ber. 1948;81(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):12–9.

    Article  CAS  Google Scholar 

  • Sharma R, Lawrenson AS, Fisher NE, Warman AJ, Shone AE, Hill A, Mbekeani A, Pidathala C, Amewu RK, Leung S, Gibbons P, Hong DW, Stocks P, Nixon GL, Chadwick J, Shearer J, Gowers I, Cronk D, Parel SP, O'Neill PM, Ward SA, Biagini G, Berry NG. Identification of novel antimalarial chemotypes via chemoinformatic compound selection methods for a high-throughput screening program against the novel malarial target, PfNDH2: increasing hit rate via virtual screening methods. J Med Chem. 2012;55(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):3144–54.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Skerlj RT, Bastos CM, Booker ML, Kramer ML, Barker Jr RH, Celatka CA, O’Shea TJ, Munoz B, Sidhu AB, Cortese JF, Wittlin S, Papastogiannidis P, Angulo-Barturen I, Belen Jimenez-Diaz M, Sybertz E. Optimization of potent inhibitors of P. falciparum dihydroorotate dehydrogenase for the treatment of malaria. Acs Med Chem Lett. 2011;2(9):708–13.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Spencer CM, Goa KL. Atovaquone – a review of its pharmacological properties and therapeutic efficacy in opportunistic infections. Drugs. 1995;50(1):176–96.

    Article  CAS  PubMed  Google Scholar 

  • Srivastava IK, Rottenberg H, Vaidya AB. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J Biol Chem. 1997;272(7):3961–6.

    Article  CAS  PubMed  Google Scholar 

  • Thapar MM, Ashton M, Lindegardh N, Bergqvist Y, Nivelius S, Johansson I, Bjorkman A. Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis. Eur J Clin Pharmacol. 2002;58(1):19–27.

    Article  CAS  PubMed  Google Scholar 

  • Vyas VK, Ghate M. Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors. Mini Rev Med Chem. 2011;11(12):1039–55.

    Article  CAS  PubMed  Google Scholar 

  • White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother. 1997;41(7):1413–22.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Winter RW, Kelly JX, Smilkstein MJ, Dodean R, Hinrichs D, Riscoe MK. Antimalarial quinolones: synthesis, potency, and mechanistic studies. Exp Parasitol. 2008;118(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):487–97.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Xiang H, McSurdy-Freed J, Moorthy GS, Hugger E, Bambal R, Han C, Ferrer S, Gargallo D, Davis CB. Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor. J Pharm Sci. 2006;95(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):2657–72.

    Article  CAS  PubMed  Google Scholar 

  • Yeates CL, Batchelor JF, Capon EC, Cheesman NJ, Fry M, Hudson AT, Pudney M, Trimming H, Woolven J, Bueno JM, Chicharro J, Fernandez E, Fiandor JM, Gargallo-Viola D, Gomez d l H F, Herreros E, Leon ML. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials. J Med Chem. 2008;51(Copyright (C) 2013 American Chemical Society (ACS). All Rights Reserved):2845–52.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK

    Gemma L. Nixon, Stephen A. Ward & Giancarlo A. Biagini

  2. Department of Chemistry, University of Liverpool, P.O. Box 147, Liverpool, L69 3BX, UK

    Paul M. O’Neill

Authors
  1. Gemma L. Nixon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen A. Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul M. O’Neill
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giancarlo A. Biagini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gemma L. Nixon .

Editor information

Editors and Affiliations

  1. Heswall, United Kingdom

    Marcel Hommel

  2. Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany

    Peter G. Kremsner

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Nixon, G.L., Ward, S.A., O’Neill, P.M., Biagini, G.A. (2014). Inhibitors of the Plasmodium Mitochondrial Respiratory Chain. In: Hommel, M., Kremsner, P. (eds) Encyclopedia of Malaria. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8757-9_15-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8757-9_15-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-8757-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation